Literature DB >> 22299590

Mutation analysis of the CFTR gene in 225 children: identification of five novel severe and seven reported severe mutations.

Kabir Sachdeva1, Renu Saxena, Ratna Puri, Sunita Bijarnia, Sudha Kohli, Ishwar Chander Verma.   

Abstract

BACKGROUND: Cystic fibrosis (CF) is the most common inherited disorder in Caucasian populations, with more than 1400 cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations. The type of mutations and their distributions varies widely between different countries and/or ethnic groups.
METHODS: We characterized the mutations in the CFTR gene by single-strand conformation polymorphism followed by sequencing in CF patients.
RESULTS: Twelve mutations were found in 79/225 (35.1%) patients. The most frequent mutations were F508 deletion (31.1%), p.R1162× (2.2%), p.M1T (0.8%), and S559N (0.8%). Five novel severe mutations (p.R80N11fs*11, p.R75G, p.Y577×, p.Y808Yfs*10, and p.I331×) and three reported mutations (p.C343×, p.Ile1000×, p.M469V) were detected.
CONCLUSION: The protocol for identification of mutations in cases of CF in developing countries would have to include a different set of mutations than those reported from western countries.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22299590     DOI: 10.1089/gtmb.2011.0283

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  7 in total

Review 1.  Ivacaftor: a novel mutation modulating drug.

Authors:  Harit Kapoor; Astha Koolwal; Ankur Singh
Journal:  J Clin Diagn Res       Date:  2014-11-20

2.  Medical genetics and genomic medicine in India: current status and opportunities ahead.

Authors:  Shagun Aggarwal; Shubha R Phadke
Journal:  Mol Genet Genomic Med       Date:  2015-05       Impact factor: 2.183

Review 3.  Genomics of rare genetic diseases-experiences from India.

Authors:  Sridhar Sivasubbu; Vinod Scaria
Journal:  Hum Genomics       Date:  2019-09-25       Impact factor: 4.639

4.  Cystic fibrosis revisited.

Authors:  H Kulkarni; S Kansra; S Karande
Journal:  J Postgrad Med       Date:  2019 Oct-Dec       Impact factor: 1.476

5.  NGS-based expanded carrier screening for genetic disorders in North Indian population reveals unexpected results - a pilot study.

Authors:  Kanika Singh; Sunita Bijarnia-Mahay; V L Ramprasad; Ratna Dua Puri; Sandhya Nair; Sheetal Sharda; Renu Saxena; Sudha Kohli; Samarth Kulshreshtha; Indrani Ganguli; Kanwal Gujral; Ishwar C Verma
Journal:  BMC Med Genet       Date:  2020-11-02       Impact factor: 2.103

6.  Racially equitable diagnosis of cystic fibrosis using next-generation DNA sequencing: a case report.

Authors:  Bennett O V Shum; Glenn Bennett; Akash Navilebasappa; R Kishore Kumar
Journal:  BMC Pediatr       Date:  2021-03-31       Impact factor: 2.125

7.  CFTR gene variants in Indian congenital bilateral absence of vas deferens & its relevance in genetic counselling.

Authors:  Ashutosh Halder; Deepak Pandey
Journal:  Indian J Med Res       Date:  2020-12       Impact factor: 2.375

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.